Wise, M.G.; Karlowsky, J.A.; Polis, T.J.; Siddiqui, F.; Young, K.; Motyl, M.R.; Sahm, D.F.
Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016–2024. Antibiotics 2025, 14, 1018.
https://doi.org/10.3390/antibiotics14101018
AMA Style
Wise MG, Karlowsky JA, Polis TJ, Siddiqui F, Young K, Motyl MR, Sahm DF.
Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016–2024. Antibiotics. 2025; 14(10):1018.
https://doi.org/10.3390/antibiotics14101018
Chicago/Turabian Style
Wise, Mark G., James A. Karlowsky, Thales J. Polis, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, and Daniel F. Sahm.
2025. "Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016–2024" Antibiotics 14, no. 10: 1018.
https://doi.org/10.3390/antibiotics14101018
APA Style
Wise, M. G., Karlowsky, J. A., Polis, T. J., Siddiqui, F., Young, K., Motyl, M. R., & Sahm, D. F.
(2025). Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016–2024. Antibiotics, 14(10), 1018.
https://doi.org/10.3390/antibiotics14101018